Skip to main content
logo
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.130
+0.010 (0.89%)
At close: Sep 1, 2026, 4:00 PM EDT
1.142
+0.012 (1.09%)
After-hours: Sep 1, 2026, 7:21 PM EDT

Sunshine Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
35.3536.3134.8724.094.350.23
Revenue Growth
-2.74%4.11%44.75%454.42%1802.41%219.88%
Gross Profit
10.7112.2610.678.341.70.11
Operating Income
-5.2-4.48-5.81-4.79-8.67-2.44
Net Income
-5.83-5.98-5.13-4.51-26.74-12.44
Earnings Per Share
-8.20-14.37-73.16---
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.039.129.6916.2921.832.05
Total Debt
0.680.810.950.660.771.9
Net Cash (Debt)
13.358.318.7315.6321.060.15
Net Cash Growth
42.40%-4.84%-44.14%-25.77%13687.37%-
Net Cash Per Share
18.7619.99124.46---

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.35-5.33-12.52-8.78-5.25-1.83
Capital Expenditures
-0.02-0.17-1.66-0.08-0.19-
Free Cash Flow
-5.37-5.51-14.18-8.86-5.44-1.83
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
30.30%33.76%30.59%34.61%39.04%48.42%
Operating Margin
-14.71%-12.34%-16.67%-19.86%-199.61%-1068.24%
Pretax Margin
-15.73%-16.40%-15.40%-17.06%-610.07%-5444.41%
Profit Margin
-16.50%-16.46%-14.72%-18.70%-615.44%-5444.41%
FCF Margin
-15.20%-15.16%-40.67%-36.76%-125.24%-800.75%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-38.250.26---
PS Ratio
0.120.170.170.293.33131.01